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ABSTRACT
IN VIVO LABELING OF A MODEL β-CLAM PROTEIN
WITH A FLUORESCENT AMINO ACID
SEPTEMBER 2010
MANGAYARKARASI PERIASAMY,
B.S., NIZAM COLLEGE INDIA
M.S., OSMANIA UNIVERSITY INDIA
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Lila M Gierasch
Proteins can be labeled with different tags to enable their structural and functional
investigations. In addition, labeling proteins at specific sites helps in studying the
conformational dynamics of these molecules. A plethora of methods is available to
facilitate labeling, choice of which largely depends on the requirements and the
anticipated end results. In general, the various labeling methods can be classified into
four different classes based on the stage at which labeling is performed, namely post
translational labeling, non-ribosomal synthesis, in vitro translation and in vivo translation.
Interestingly all these techniques use different unnatural amino acids for this purpose.
Protein folding is one among the many applications that requires tailoring proteins with
special molecules or labels for deducing the folding pathway. Understanding the protein
folding problem is a key for answering questions concerning protein behavior and thus,
will provide strategies to solve protein misfolding diseases. Protein folding is one among
the unsolved problems in biology and in particular understanding the in vivo behavior of
proteins in the complex cytoplasm environment with a cellular density of approximately
350 to 400 mg/ml is more critical. It is evident that there is a difference in the behavior
and folding of proteins in vivo and in vitro and to deduce more insights in this aspect the
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protein of interest is to be labeled with a sensitive probe. The in vivo translation method
offers a good method of choice for labeling the protein at a specific position and
monitoring its behavior.
To study the ultimate goals of acquiring knowledge of the in vivo behavior and folding
characteristics of proteins, the first step of establishing an efficient labeling technique is
quintessential and as a starting step, this project aims to label a β-clam protein, cellular
retinoic acid binding protein I (CRABP I) a 136 amino acid protein, with a sensitive
unnatural fluorescent amino acid probe in vivo in E. coli cells.
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CHAPTER 1
INTRODUCTION
1.1 Protein labeling strategies
Designing and tailoring proteins are major tools facilitating molecular studies of various
types. Apart from being tools in enhancing protein investigations, these designer proteins
will make their way into many other applications too (Dougherty, 2000; Wang and
Schultz, 2004). This is promising especially for protein folding investigations. Labeling
proteins can be essentially performed by post-translational modification, non-ribosomal
synthesis and in vitro and in vivo translation methods using non natural amino acids. Non
natural amino acids serve as spin labels, fluorescent amino acids, cross-linking agents and
other spectroscopic and mechanistic probes (Dougherty, 2000; Hendrickson et al., 2004).
In this process, scientists have managed to extend the 64 triplet genetic code allowing for
decoding the ‘amber’ stop codon for a non natural amino acid. This library of available
unnatural amino acids is presently being extended. These are amino acids designed to
serve a purpose which will exclusively lead to production of labeled proteins with the
desired unnatural amino acid at a specific position that will eventually serve as a tag for
molecular protein studies.
The available methods for incorporation of unnatural amino acids include: use of amino
acid auxotrophs (‘residue specific’ incorporation of non-canonical amino acid) (Kiick et
al., 2001), in vitro translation with chemically altered aminoacylated tRNAs, SELEX of
ribozymes, solid phase peptide synthesis (SPPS), cyanogens bromide cleavage and
peptide religation, import of aminoacylated amino acids into eukaryotic cells, unnatural
amino acid incorporation using orthogonal aminoacyl synthetase and tRNA pairs and
chemical modification of amino acids (Baslé et al., 2010). Among these the orthogonal
1

synthetase and tRNA pair can be specifically used complementary to nonsense codon,
four base or five base codons (Kiick et al., 2001).
1.2 Method of choice for labeling
The phenomenon of nonsense suppression has been known and worked upon from the
1960’s. However, the first attempts to introduce unnatural amino acids at specific sites in
a protein were accomplished in a cell free translation system by the Peter Schultz group
(Noren et al., 1989). They employed chemically acylated tRNAs with the unnatural
amino acids for this purpose. The in vivo approach of the same technique was started with
the aim to enhance the value of the method in cells and avoid the laborious biochemical
procedure involved in the former.
The beauty of the method is the use of the cell’s own machinery to translate the labeled
protein unlike in the in vitro techniques. This technique when compared to the in vitro
translation labeling can be viewed being cost effective and also efficient (Ohno et al.,
1998). This method has paved the way for using small chemical molecules with special
properties to label proteins, unlike the available labels that are comparatively larger in
size and toxic to cells. In comparison with the chemical aminoacylation of the tRNAs in
vitro and subsequent microinjection into eukaryotic cells this method impressively
exploits the cells machinery for doing so. This technique allows for the desired protein
modification under native conditions in the intracellular environment.
When compared to the ‘residue specific’ incorporation of non-canonical amino acid in
which the sense codons coding for a particular natural amino acid are reassigned with the
unnatural or non-canonical amino acid by altering the amino acid pool (Link and Tirrell,
2005), the in vivo nonsense codon suppression technique is highly specific in terms of
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position and not residue. Unlike ‘residue specific’ incorporation, this process lacks the
editing step consequent to misacylation of tRNAs with unnatural amino acids in the
ribosome (Effraim et al., 2009). There are often problems of introducing analogues
nonselectively at the locations for the residue specific incorporation (Furter, 1998).
However following steps might be effected which could be a plausible reason for the low
level of expression. These factors are still unknown to large extent. In addition the
nonsense suppression technique has been applied in mammalian cells, yeast, E. coli and
also other bacterial genera like Mycobacterium (Wang et al., 2010).
Nonsense suppression mediated labeling is facilitated by the presence of the unnatural
amino acid in the medium of the E. coli culture, specific tRNAs that can recognize the
amber stop codon and bind specifically to the unnatural amino acid in the amino acid
binding pocket and the specific aminoacyl tRNA synthetase that recognizes the specific
loaded tRNA and the unnatural amino acid.
1.3 Nonsense suppression technique
There are three mRNA codons recognized as stop signals for protein translation, viz.
amber (UAG), opal (UGA) and ochre (UAA). Among these there is a preference for use
of a particular stop codon more frequently in particular living systems for example, E.
coli protein genes carry the ochre stop codon as the stop signal whereas eukaryotic
systems use the amber codon for the same purpose. This fact is exploited to introduce an
unnatural amino acid apart from the twenty natural amino acids at the infrequently used
stop codon in E. coli.

3
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Fig 1.1 Schematic of the working mechanism of the nonsense suppression technique. The
ribosomes are shown in red, grey and brown. The various ingredients of the translation
process are depicted, viz. tRNA, mRNA, unnatural amino acid (UA) acylated to the
respective tRNA (in blue)(Wang and Schultz,2004).

For any amino acid to be incorporated at a particular position in a polypeptide it has to be
recognized by a specific tRNA to which it should be acylated by a specific aminoacyl
tRNA synthetase with specific recognition for the former two. The tRNA carries the
complementary anticodon to the particular sequence on the mRNA. Hence the fidelity of
the reaction is mainly attributed to the recognition of the entities and hence the
specificity.
These are taken advantage of to facilitate labeling of a protein during the process of
translation. This technique makes it possible to incorporate an unnatural amino acid of
choice at a position in a protein encoded by the amber (UAG) stop codon. In the presence
of a modified tRNA that recognizes the UAG codon at the particular position and the
specific aminoacyl tRNA synthetase the unnatural amino acid of choice is incorporated in
the protein as shown in Fig 1.1. To avoid the ability of the tRNA to get acylated by any
of the cell’s own synthetases the system is so designed that both the tRNA and the
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synthetases are ‘orthogonal’ to the system used for protein expression and has been
shown not to be involved in the cells native functions. Since the process takes place in
vivo, the other requirements for the translation process to take place are taken care of by
the cells.
The ingredients that function in this incorporation method are mutant orthogonal tRNA,
mutant orthogonal aminoacyl tRNA synthetases and the unnatural amino acid. Each of
these ingredients has certain properties aiding for their function and each of these is being
discussed ahead.
1.4 Ingredients for nonsense suppression technique
•

Suppressor tRNA

The suppressor tRNA used must meet two criteria: 1) it must efficiently insert the desired
amino acid in response to the UAG codon, and 2) it must not be acylated by any of the E.
coli’s aminoacyl tRNA synthetases present in vivo. These two factors are necessary to
obtain the desired protein to be labeled and not to obtain any mislabeled protein product.
The amber suppressor tRNAs in our experiments are derived from Methanococcus
jannaschii, a thermophilic archaeabacterium. The tRNA is an MjtRNATyrCUA originally
destined to carry a tyrosine molecule. It has been observed that the same tRNA derived
from S. cerevisiae and H. sapiens is not orthogonal in E. coli (Wang and Schultz, 2004).
The M. jannaschii tRNA was hence chosen. The Schultz group has mentioned that
although the tRNA is well recognized by the corresponding aminoacyl MjtRNA
synthetase it can also at low levels be aminoacylated by the E. coli aminoacyl tRNA
synthetases.
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Fig. 1.2 Structure of tRNAs A.Comparison of the structure of the tRNAs from different
organisms. B.Anticodon-loop tRNA library (left) and all-loop tRNA library (right) derived
from M. jannaschii tRNATyr CUA. Randomly mutated nucleotides (N) are shaded in black.

To overcome this, the group had made positive and negative selections with a mutant
tRNA library in the absence and presence of the cognate aminoacyl tRNA synthetases in
E. coli. The amber codon in barnase gene was used for selection of clones that could only
survive when provided with the orthogonal tRNA. The next selection was done for the
cognate aminoacyl tRNA synthetases (Wang and Schultz, 2001).
It is known that the concentration of suppressor tRNA in the cell may cause detrimental
effects to the cell. Hence, the level of expression of the tRNA is also to be regulated
(Miller, 1991).
•

Aminoacyl-tRNA synthetases

Mutant orthogonal aminoacyl tRNA synthetases are used to suppress the amber codon in
E. coli and incorporate the unnatural amino acid in response to the amber codon. MethylO-tyrosine was one among the first candidates to be used in the field of nonsense
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suppression being recognized by orthogonal MjtRNA and aminoacyl tRNA synthetase
pair specially mutated and selected for this purpose (Wang and Schultz, 2004).
Tyrosyl tRNA synthetase has no proofreading capacity and hence is chosen against
Glutaminyl tRNA synthetase earlier studied. It has also been observed that the
synthetases from archaea can be efficiently expressed in E. coli in the active form as
opposed to the eukaryotic counterparts. The aminoacyl MjTyrtRNA synthetase
discriminates tRNAs with C1:G72 (an eukaryotic recognition element) from those with
G1:C72 (prokaryotic recognition element) and it does not aminoacylate E. coli tRNA.
The aminoacyl MjTyrtRNA synthetase is devoid of the C-terminal binding domain for
the anticodon loop of its tRNATyr. This shows that the recognition elements of their
aminoacyl tRNA synthetase is far different from the E. coli’s and provides the basis for
orthogonality. Another factor that it facilitates is that the mutation in the anticodon loop
of the tRNA to recognize amber codon would not interfere and affect the recognition and
binding. Structure-based mutagenesis and a similar two-step selection strategy are used
to alter the specificity of the heterologous aminoacyl tRNA synthetase so that it uniquely
recognizes the unnatural amino acid (UA) of interest.
The fidelity of translation of a polypeptide is determined by the availability of the amino
acyl-tRNA composed of the cognate amino acid:tRNA pairs and the accurate selection of
the aminoacyl-tRNAs on the ribosome (Ling et al., 2009). Amino acids that differ by for
example a single methyl group are often not that well differentiated by the aminoacyl
tRNA synthetases and hence contributing to the translation error rate. However, the cell
is equipped with the necessary editing machinery to cope up with such situations. This
editing machinery is deceived in this process of nonsense suppression. Nevertheless,
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there is a percentage of loss during this process and hence lowering the yield of the
protein being formed. The engineered aminoacyl MjTyrtRNA synthetase structure has
been obtained by x-ray crystallography (Wang and Schultz, 2001).

Fig.1.3 Crystal structure of apo wild-type M. jannaschii TyrRS. (A) Overall structure of apo
M. jannaschii TyrRS homodimer. The N-terminal catalytic domain (blue and red) is
connected via the signature KMSKS loop to the C-terminal anticodon recognition domain
(green and cyan). (B) Stereo view of the superimposition of wild-type M. jannaschii TyrRS
and OMeTyr-specific mutant synthetase to illustrate conformational differences. Apo
mutant M. jannaschii TyrRS is colored by its rms deviation (C ) from the apo wild-type
TyrRS structure (gray) with a gradient ranging from low (0.2 Å, green) via medium (1.8 Å,
yellow) to high (>4.0 Å, red). (C) Stereo view of OMeTyr-specific mutant synthetase
superimposed with wild-type apo M. jannaschii TyrRS (gray) to highlight mutated residues.
The mutant enzyme is colored with cyan helices and pink -strands. The four residues
subjected to mutation are represented by ball-and-stick with their oxygen atoms colored
red. Bonds/carbon atoms are colored green in the mutant enzyme but blue in wild-type
(Zhang et al., 2005).

The aminoacyl MjTyrtRNA synthetase is 18 % identical to that of Bacillus
stearothermophilus, 22 % identical to that of Thermus thermophilus and 37 % identical to
the human TyrRS catalytic domain. While the overall fold of the apo aminoacyl
MjTyrtRNA synthetase is identical to its counterpart with tRNA and tyrosine with an
overall rmsd (Cα) of 1.5 Å, the active-site mutations result in hydrogen bonding and
steric interactions favoring binding of Methyl-O-tyrosine over L-tyrosine. It has been
found that the aminoacyl MjtRNA synthetases have higher degree of plasticity when
compared to the other counterparts that enables their ability to be used for nonsense
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suppression (Turner et al., 2006). The tRNA and synthetase pair was first discovered for
suppression of the amber codon using the endogeneous amino acid pool (Wang and
Schultz, 2001).
1.5 Essential elements for the feasibility of the nonsense suppression technique
1.5.1 Overexpression of aminoacyl-tRNA synthetases
The activity of this enzyme is a critical controlling factor in determining the success rate
of the incorporation of the unnatural amino acid at the specific position.
The different promoter elements controlling the synthetase enzyme expression developed
by the Schultz group have recently been tested for the incorporation efficiency using
amber mutant GFP (Young et al., 2010). It is evident from these results that the gene for
synthetase enzyme when under control of the E. coli constitutive glnRS promoter yields
lesser GFP product than under control of araBAD promoter. However contrasting results
have been observed by these workers in other systems. The synthetase gene for the
fluorescent amino acid and the methyl tyrosine incorporation are under the control of the
E. coli constitutive glnRS promoter. However the expression level of the product in case
of the latter is higher than with the fluorescent amino acid showing that this expression
level (definitely lower than the wild type expression) of synthetases is not the critical
factor.
1.5.2 Aminoacyl-tRNA synthetase activity
The unnatural amino acid is activated by binding to the binding pocket in the synthetase
enzyme. The editing activity by which misincorporation is avoided by the natural system
is inactivated in this case hence allowing for the incorporation of the unnatural amino
acid (Hendrickson et al., 2004).
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1.5.3 Amber stop codon
The UAG amber stop codon is used for the assignment of an unnatural amino acid since
this codon is more easily suppressed by a tRNA bearing CUA anticodon competing with
the release factor 1 (RF1) in E. coli (Hayashi et al., 2010). The amber codon is a rarely
used stop codon in E. coli i.e 93 % of E. coli genes end with TAA or TGA and not TAG
(Young and Schultz, 2010). The criterion for the nonsense suppression technique is that
the unique codon must be recognized by the new tRNA but not by any endogenous
tRNAs hence the amber codon will serve this purpose well. It has been shown that
expressing proteins with rare codons used by bacteria leads to long pauses by the
ribosome leading to differences in folding and insolubility of the proteins. However if
provided with the required tRNAs this will be combated for. Decreasing the temperature
while the bacteria are expressing the protein leads to increasing the solubility of the
protein and lowers the overall protein synthesis preventing saturation of the cellular
folding machinery with the over expressed recombinant proteins (Rosano and Ceccarelli,
2009). Another aspect to keep in mind is the context of the amber codon. UAG followed
with A are suppressed efficiently, if followed by G are moderately suppressed and those
followed by U and C are said to be poorly suppressed. The CUX codon after the UAG
however is said to be efficient. The AUX is the most efficient. In our case the UAG
codon is followed by ACT. Since there is an A post UAG it is supposed to be efficient
(Miller, 1991).
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1.5.4 Unnatural amino acids
The 21st amino acid selenocysteine is incorporated in response to UGA stop codon which
forms the basis for expanding the genetic code in E. coli for labeling proteins (Chambers
et al., 1986). Amino acids with different chemical handles, fluorescent probes, redox
active groups or heavy atoms offer a great probe tool box for manipulating protein
function in vitro and in vivo (Chin et al., 2002; Deiters et al., 2005; Liu et al., 1997;
Fleissner et al., 2009; Hartman et al., 2007). One of the major requirements of the
procedure to be successful is the ability for the amino acid to be transported to the
cytoplasm of the cell from the medium. The unnatural amino acid should be
metabolically stable, should be available for the cells machinery, it must be tolerated by
EF-Tu and the ribosome, but it must not be a substrate for any endogenous aaRSs. Most
unnatural amino acidss added to the media are taken up by both prokaryotic and
eukaryotic cells (exceptions include highly charged amino acids, which can be modified
as metabolically labile derivatives or incorporated into dipeptides to increase
permeability) (Zhang et al., 2005). Some unnatural amino acids that have already been
applied for labeling proteins are 2-amino-3-(4-(trifluoromethoxy) phenyl) propanoic acid
(OCF3Phe), 13C/15N-labeled p-methoxyphenylalanine (OMePhe), and
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N-labeled o-

nitrobenzyl-tyrosine (oNBTyr) (Cellitti et al., 2008), p-azido-L-phenylalanine (Chen et
al., 2008), benzyl phenylalanine (Ryu and Schultz, 2006; Chin et al., 2002), p-acetyl-Lphenylalanine (Fleissner et al., 2009).
L-(7-hydroxycoumarin-4-yl) ethyl glycine (HCEG) was chosen for the incorporation into
CRABPI on account of its high quantum yield, large Stoke’s shift, small size and
sensitivity to pH (Adamczyk et al., 1997). The other amino acid that is chosen to support
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the labeling studies is Methyl-O-tyrosine. The methyl-O-tyrosine is a tyrosine analog
with the para hydroxyl group substituted with a methoxy group (Wang and Schultz,
2001).
Transport of the unnatural amino acid into the E. coli cells takes place passively. Polar
molecules are transported across membranes through transmembrane channels. It is
known that unlike small molecules like ions large molecules like glucose and amino acids
are transported through the membranes by special carriers like permeases. This process is
energy independent.
1.5.5 Efficient systems for nonsense suppression expression
Considering the pitfalls especially low level expression of labeled protein, certain amount
of tweezing of the plasmid and respective promoters have been made to allow for higher
level expressions of the tRNA, synthetase and eventually in the process the labeled
protein (Ryu and Schultz, 2006). Plasmid systems with multiple copies (polycistronic) of
the tRNA gene under the proK promoter are designed and the efficiency of protein
expression has been claimed to be increased to 40 mg/l from 2 mg/l (Ryu and Schultz,
2006).
The nonsense suppression technique is hence a reasonably good method of choice for
labeling proteins in vivo and offers promising strategies if all the parameters explained
before are satisfied.
1.6 Labeling a β-clamp protein
We are interested to study the in vivo dynamics of CRABP I in the E. coli cytoplasm for
which we have chosen to label the protein with a fluorescent unnatural amino acid in vivo
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using the nonsense suppression technique. A general schematic of the goal is shown in
Fig 1.4.

Fig 1.4 Schematic representation of labeling of CRABP I with the fluorescent amino acid
using the nonsense suppression technique (Wang et al., 2006)

CRABP I is a 136 amino acid long model β-clam protein whose in vitro folding
mechanism has been well studied in the lab. However, very less is known about the in
vivo folding mechanism of this protein which is expected to be very different from the in
vitro observations on account of the macromolecular crowding in the cytoplasmic
context. The average cytoplasmic density in E. coli is estimated to be around 350-400
mg/ml. It can be predicted that this high density will induce variability in the in vivo
folding mechanism of the protein which would like to be investigated using in vivo tools.
Fluorescence labeling offers a good scope of learning this aspect in addition to being a
sensitive technique. In vivo fluorescence resonance transfer (FRET) experiments will be
performed using compatible dyes at different calculated positions to study the in vivo
protein dynamics and as a first step labeling of the protein in vivo at a specific position
with a comparatively small fluorescent dye has been done as a first step to accomplish
these studies.
13

CHAPTER 2
MATERIALS & METHODS
2.1 Choice of the unnatural amino acid
L-(7-hydroxycoumarin-4-yl) ethyl glycine was chosen on account of its high fluorescence
quantum yield of 0.63, large Stoke’s shift of approximately 100 nm, small size of 264 Da
and sensitivity to pH. It was synthesized following the Pechman condensation reaction
and purified. Incorporation in response to the amber codon TAG by the orthogonal pair
of Methanococcus jannaschiii tRNATYRCUA and MjTyrRS was performed. Apart from
these properties, the chosen fluorescent amino acid has an excitation maximum at 350 nm
and emission maximum at 450 nm hence it forms good FRET pairs with FlAsH
(excitation maximum of 510 nm and emission maximum of 530 nm; L-3-(2- Naphthyl)
alanine(excitation maximum of 285 nm and emission
maximum of 335 nm; BODIPY-FL (excitation maximum of
488 nm and emission maximum of 510 nm) and tryptophan
(excitation maximum of 295 nm and emission maximum of
350 nm).
Fig 2.1 Structure of L-(7-hydroxycoumarin-4-yl) ethyl glycine

Site directed mutagenesis experiments were designed to introduce the TAG codon into
the CRABP I gene at a particular position. Following which cloning to introduce the
mutated CRABP I gene into the required plasmid was performed. Co-expression of the
stop codon containing CRABP I, MjtRNATYRCUA and aminoacyl MjTyrtRNA synthetase
was performed. Further to optimize the labeled protein expression and learn the working
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of the technique another unnatural amino acid system namely Methyl-O-Tyrosine was
also used.
Table 1 is a summary of the various unnatural amino acids developed for incorporation in
various systems among which many are under investigation. (Wang et al., 2010).

Table 1. List of the various unnatural amino acids incorporated in proteins using the in vivo
nonsense suppression method (Wang et al., 2010).
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•

Amber codon in CRABP I:

The Lysine 106 position in CRABP I was chosen for mutagenesis to the amber codon.
This position is present in the Ω loop as observed in Fig 2.2. The sequence variation in
the Ω loop among various iLBP (intracellular Lipid Binding Protein) members shows low
sequence conservation (Kohrer et al., 2003) minimal or no secondary and tertiary
structure perturbation, accessible molecular surface, other possible interactions and free
accessibility.
•

Site of incorporation:

The incorporation of the unnatural amino acid at the specific site has been known to have
a relation with the site chosen for incorporation. However, the exact rules governing this
factor are not yet formed (Young et al., 2010). Using an earlier position in the gene of
interest restricts the observation of truncated products. In the 1998 Ohno et al. (Ohno et
al., 1998) have used the 126 position in the β-lactamase gene but only measure the
activity of the protein. While in papers later an earlier position facilitating N-terminal
sequencing (Furter, 1998) has been used. However, there is also evidence of truncation
(Liu et al., 1997).

Fig 2.2 Structure of CRABP I. The Lysine-106 position is shown as red spacefill.
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2.3 Plasmids and genes
The pBAD/JYAMB-4TAG-Myo and pBK-CouRS-D8 plasmids (Wang et al., 2006) were
offered by the Schultz lab. The pBAD plasmid carries the mutant sperm whale myoglobin
gene with the amber codon at the Serine 4 position, mutated MjtRNA gene and
tetracycline resistance gene as a selective marker.

Fig 2.3 Vector map of pBAD-myo-wt plasmid as provided by the Schultz laboratory

The myoglobin gene is under the arabinose promoter and rrnB terminator. The MjtRNA
gene is with the lpp promoter and rrnC terminator. The lpp (lipoprotein) promoter is a
highly efficient constitutive promoter usually used for in vivo RNA expression (Umekage
and Kikuchi, 2009). The pBK plasmid carries the aminoacyl MjTyrtRNA synthetase
(MjTyrRS) gene in which the residues have mutations as follows; Tyr32 Glu, Leu65 His,
Ala67 Gly, His70 Gly, Phe108 Tyr, Gln109 His, Asp158 Gly and Leu162 Gly. The four
glycine mutations offer space for accommodation of the unnatural amino acid. Tyr32 and
Asp158 which are involved in hydrogen bonding to the native substrate, tyrosine are
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mutated to loose activity towards tyrosine. The plasmid has the kanamycin gene as a
selection marker.
For the Methyl-O-Tyrosine incorporation the pSup-JYRS plasmid was obtained from the
Schultz group. This system has been observed to be more efficient for unnatural amino
acid incorporation when compared to the pBK system (Young et al., 2010). The vector
carries the JYRS (synthetase), two tricistronic clusters of the tRNA (JYTRN) gene and
chloramphenicol resistance gene. The synthetase gene is under the control of a modified
glnS’ promoter. The tRNA genes are under the control of the proK promoter.

Fig 2.4 Vector map of pSup-JYRS plasmid for the incorporation of O-Methyl-tyrosine (as
provided by the Schultz group)

2.4 Comparison of the systems for 7-Hydroxycoumarin-4-ethyl glycine and methylO-tyrosine incorporations:
Young et al. have provided comprehensive explanation for the new plasmid system
(pSup) with enhanced expression levels of labeled protein with unnatural amino acids.
These plasmids are designed to facilitate the gene of interest to be encoded in colE1 or
pBR322 origin plasmids. In this case the gene of interest can be under a system of higher
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expression like the T7 promoter, unlike pBAD. This facilitates higher expression of the
labeled protein. A similar system has been constructed for the fluorescent amino acid
labeling recently. However, the expression of the tRNA genes in case of pSup vector
under the control of the prok promoter has been observed to slow down the growth
phenotype. This system has been used for longer induction times of 12-14 Hrs and it has
been observed that the growth temperature had no particular effect on the expression of
the protein.

2.5 Competent cells:

Fig 2.5 Comparison of the protein expression levels using different incorporation systems
(From Travis S.Young et al., 2010)

The type of competent cells also plays a role in expression of the various components and
the final expression of the labeled product. Expression of GroEL using different vector
systems in different competent cells has been performed and it is found that the
expression from pSUP is best in BL21(DE3) cells where as expression from pBK is best
in DH10B cells (Young et al., 2010). As observed in the Fig 2.5 the expression levels
while using the pSup system is higher when compared to that of the pBAD-pBK. Based
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on these they have developed a pEVOL plasmid system for the incorporation of the
fluorescent amino acid into any protein of interest that can be encoded in a pET vector.
This would be a simpler system giving high yields of labeled protein expression for us.
The system has been requested from the Schultz lab.

2.6 Culture Medium:
Suppression of protein with amber codon when expressed with synthetase gene has been
observed even in the absence of the unnatural amino acid in 2XYT (rich medium).
However this background is not observed when expressed in GMML medium (minimal
medium). It should be noted that this kind of background incorporation occurs by
aminoacylation of the suppressor tRNAs by the evolved synthetase with an endogeneous
amino acid (usually Phe, Tyr) in rich media in the absence of the cognate unnatural
amino acid. This background incorporation is typically suppressed by the addition of
cognate unnatural amino acid to the expression media (Young et al., 2010).

2.7 Factors to consider while using the nonsense suppression technique
Based on literature and results the following can be laid out as basic considerations while
using the nonsense suppression technique for labeling proteins in vivo;
1. The codons chosen to be mutated to the amber codon are minor/major for the
particular amino acid. Very often the neighboring residues are important in the
interpretation of the nonsense codon by the ribosome due to wobble effect
(Finkel, 2010).
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2. While designing the site for UAG mutation, care was taken to prevent the
presence of unfavorable amino acids like leucine, arginine and serine codons
following the UAG as these are highly degenerate.
The amino acid pool in the E. coli cytoplasm was defined by researches much earlier
(Britten and McClure, 1962). Researchers usually use M9 minimal medium for labeling
purposes as this would define the amino acid pool in E. coli (Link and Tirrell, 2005).
However, the Schultz group has obtained similar labeled protein yields in the rich 2XYT
medium and in the minimal medium M9. Hence, unlike the residue specific labeling
wherein the cells are regulated with the amino acids provided with, this method does not
require the stringency in that sense. The only major limiting factors regarding the
presence of the unnatural amino acid in the total cytoplasmic amino acid pool are the
metabolic stability of the unnatural amino acid and the bioavailability of the amino acid
to the cells.
The kinetics of adenylate formation with ATP catalyzed by the mutant TYRS was tested
by the Schultz group in vitro and was found that the Kcat/Km of the mutant TYRS for
Methyl-O-tyrosine is 100 fold higher than that for tyrosine. The physiological
concentration of tyrosine in the E. coli cytoplasm is estimated to be 80 µM, which is far
below the Km i.e 5833 µM of the mutant TYRS for tyrosine. In case of Methyl-Otyrosine the concentration of the methyl tyrosine in treated cells is comparable or greater
than the Km which is 443 µM (Wang et al., 2006).
3. Misacylation of the unnatural amino acid with a native amino acyl tRNA
synthetase to the tRNA.
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Cells contain a distinct amino acyl tRNA synthetase for each of the 20 amino acids.
There is a possibility of the catalysis of the acylation by a native aminoacyl tRNA
synthetase rather than the specific orthogonal synthetases (Furter, 1998). The Schultz
group claim that this has been taken care of by the screening supported by the structure
based specificity assays. However in case this happens, the labeled protein will still be
formed.
4. Expression levels
It has been observed that the level of expression when compared to the wild type protein
is less. This is a result of cumulative factors including ribosomal pause at the stop codon,
the intracellular availability and proximity of the tRNA, synthetase and the unnatural
amino acid. The catalysis or the acylation efficiency, cross reactivity, mis acylation and
miscarriage with the endogenous entities at each step are some of the aspects that will
influence the efficiency of the incorporation.
Over expressing the protein of interest by placing it under the control of an over
expressing induction system like T7 promoter will lead to the formation of higher
amounts of the truncated products due to the imbalance between the expression level and
the ribosomal pause. Furter has observed two third expression of the protein when
compared to the wild type expression level (Furter, 1998).
5. Readthrough
Translation usually stops when the stop codon enters the A site in the ribosome. E. coli
has two release factors (RF) that facilitate in the hydrolysis of the polypeptide chain form
the last tRNA. However the stop efficiency is not 100 % and readthrough does occur.
Readthrough has been observed in E. coli in response to the amber stop codon. tRNAGln
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has been found to read the stop codon to incorporate glutamine in its place (Nilsson et al.,
2003). E. coli has two glutamine tRNAs, one decoding for CUG and the other for CAG.
This tRNA can base pair with UAG is a G-U pair is formed between the first nucleotide
in the codon and the third in the anticodon.
In E. coli the release factor (RF1) acts on UAG stop codon. The magnitude of
suppression of the stop codon has been found to be dependent on the position of the
codon based on the capacity of wobble pairing of the third position in the codon (Miller,
1991; Martin et al., 1988).
2.8 Examples of labeling proteins using the fluorescent amino acid
7-hydroxycoumarinyl-ethylglycine has been used for labeling proteins for further studies:
1. Myoglobin (PDB 105M) with 7-hydroxycoumarinyl-ethylglycine (Wang et al.,
2006).
2. The serine 4 position was labeled with the unnatural amino acid. ‘UCU’ for serine
is mutated to UAG. Not conserved and not involved in functional aspects.
3. Schultz group have applied this amino acid and labeled antibody 5C8 and
eventually tested antigen antibody interactions which supports the workability of
this technique and this particular amino acid (Mills et al., 2009).
4. Aspartate

transcarbamoylase

(1NBE),

a

153

residue

protein

with

7-

hydroxycoumarinyl-ethylglycine in a position structured in a surface exposed
loop at glycine 52 by Mendes et al. (2010).
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2.9 Chemical synthesis of L-(7-hydroxycoumarin-4-yl) ethylglycine
The fluorescent amino acid is commercially unavailable and was synthesized in house as
follows.
2.9.1 Mechanism & Synthesis:
The amino acid is synthesized following the Pechman condensation method that allows
the synthesis of coumarins by reaction of phenols with β-keto esters.
The general mechanism of the reaction is given below.
•

Mechanism

The reaction is conducted with a strong Brønstedt acid such as methanesulfonic acid or a
Lewis acid such as AlCl3. The acid catalyses transesterification as well as keto-enol
tautomerisation:

A Michael Addition leads to the formation of the coumarin skeleton. This addition is
followed by rearomatisation:

Subsequent acid-induced elimination of water gives the product:
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Following is the general scheme for the synthesis of L-(7-hydroxycoumarin-4-yl)
ethylglycine (Brun et al., 2004)

Cbz

H
N

O
OBn

a),b)

Cbz

H 2N

O

H
N

COOH

OBn

c)
O

COOH

N-α-Cbz-L-glutamic acid α-benzyl ester

OEt

O

(2S)-2-benzyloxycarbonylamino
-5-oxo-heptanedioic acid
1-benzyl ester 7-ethyl ester

O

O

OH

L-(7-hydroxycoumarin-4-yl)ethylglycine

Where, a) N,N’-Carbonyldiimidazole, RT, 2 Hrs ;b) Ethyl Magnesium malonate#, RT,
overnight;c) Resorcinol, methanesulfonic acid, RT, 2 Hrs
Ethyl magnesium malonate is synthesized from ethyl potassium malonate and magnesium
chloride and isopropanol.
The coumarinyl amino acid was synthesized by a two step process first converting N-αCbz-L-glutamic acid α-benzyl ester into the side chain β-keto ester which was then
reacted with resorcinol in methanesulfonic acid to afford the amino acid product. The
synthesis was carried out as below.

2.9.2 Synthesis methods
I. Synthesis of Ethyl magnesium malonate
1. 1.5 M Magnesium chloride + 3 M Ethyl potassium malonate + 5 volumes
Isopropanol
2. Filtration and Ethyl magnesium malonate (product) dried in vacuo
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II.Synthesis of (2S)-2-benzyloxycarbonylamino-5-oxo-heptanedioic acid 1-benzyl
ester 7-ethyl ester
1. Z-Glu-Obzl (5 g,13.46 mmol) dissolved in 50 ml dry THF at RT (4 ml/mmol
THF)
2. Carbonyl diimidazole (1.1 eq) added slowly,
3. Mixture stirred for 2 Hrs at RT, cooled to 0 0C
4. Ethyl magnesium malonate (0.55 eq) added & stirred at room temperature
overnight
5. Product extracted with ether (15-20 ml/mmol of amino acid)
6. Washed with 10 % sodium bicarbonate, water and brine
7. Residue purified by flash chromatography on silica gel (ethyl acetate:hexanes 1:1)
8. Concentrated on rotary evaporator → white solid (40 % yield).
9. 1H NMR spectra recorded on Bruker AMX-400 with chemical shifts reported
relative to tetramethylsilane.
10. LC-MS (ESI)
III.Synthesis of L-(7-hydroxycoumarin-4-yl) ethylglycine
1. (2S)-2-benzyloxycarbonylamino-5-oxo-heptanedioic acid 1-benzyl ester 7-ethyl
ester (2.35 g,5 mmol) added slowly to resorcinol (3 g, 25 mmol) in
methanesulfonic acid (20 ml)
2. Stirred 1-2 Hr at room temperature
3. Deep-red homogeneous mixture taken into 5 volumes cold ether(-30 0C)
4. Centrifuged for 20 minutes at 3600 × g
5. Discard ether
6. Precipitate washed with cold ether
7. Centrifuged 20 minutes at 3600 × g
8. Dissolved in water, filtered and Lyophilised
9. Product purified by reverse phase HPLC → brown solid in 50 % yield
(YMCAA12S052503WT column, 12 ml/min flow rate, from 10 % to 90 %
CH3CN, 0.1 % TFA (w/v) in water, over 12 min) and LC-MS (ESI).
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2.10 Molecular biology techniques
2.10.1 Cloning
The pBAD/JYAMB-4TAG-Myo and pBK-CouRS-D8 plasmids were sent by the Schultz
group (Wang et al., 2006). The plasmids were transformed in DH5α cells and tested by
sequencing and agarose gel run.
To clone the CRABP I gene into pBAD/JYAMB-4TAG-Myo in place of myoglobin the
NcoI and NdeI restriction sites were exploited. The CRABP I wt* gene in the
pET16bCRABPIwt* plasmid has the NcoI and NdeI restriction sites before the and after
the start site for the CRABP I wt* gene while the myoglobin gene in the pBAD/JYAMB4TAG-Myo vector has the NcoI and NdeI flanking sites. The NdeI site hence was
removed from its original place and reintroduced after the CRABP I gene by a two step
site directed mutagenesis. The first step was the removal of the NdeI site as depicted in
the schematic below.

NcoI

NcoI
NdeI
CRABPIwt*
CRABPIwt*

pET16b

pET16b

The second step was to introduce the NdeI site after the CRABP I wt* as shown below.

NcoI

NcoI

CRABPIwt*
CRABPIwt*

pET16b

pET16b
NdeI
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2.10.2 Site directed mutagenesis of K106 to amber codon:
The primers for site directed mutagenesis for Lysine 106 to amber codon (AAA to UAG)
in CRABPIwt* (pET16bCRABPIwt* plasmid) were designed and obtained. Site directed
mutagenesis by PCR was hence performed. The subsequent product was transformed into
DH5α cells after which the plasmid was extracted and sent for sequencing with the T7
forward primer. The schematic below represents the site directed mutagenesis step
performed.
NcoI

NcoI
CRABPIwt*

CRABPIK106Am

AAA

UAG

pET16b

pET16b

NdeI

2.10.3 Cloning of the CRABPIK106Am gene into pBAD/JYAMB-4TAG-Myo
plasmid:
The pETCRABPIK106Am plasmid was subjected to PCR amplification with the T7
forward and reverse primers. The product of which was a 944 bps in length fragment.
The PCR product is run on an agarose gel to check the presence of the amplified product.
The following procedures were followed to obtain the desired product.
2.10.4 Restriction digestions:
The

pBAD/JYAMB-4TAG-Myo

and

the

PCR

amplification

product

of

the

CRABPIK106Am gene were digested with the NcoI and the NdeI restriction enzymes to
obtain similar sticky ends. The whole product was loaded onto an agarose gel and the
required fragments were excised from the gel and purified by the Qiagen gel extraction
procedure and eluted in warm water. The following schematics depict the products
obtained as a result of the restriction digestions of the two fragments.
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CRABPIK106AmPCR
amplified fragment
NcoI

CRABPIK106Am fragment 806bp

NdeI
NdeI
Myo

pBAD/JYAMB
4TAG-Myo

NcoI

Restriction digestion product of
pBAD/JYAMB4TAG-myo

pBAD/JYAMB4TAG without myo gene
5385bps

2.10.5 Ligation of the restriction digestion fragments:
The CRABPIK106Am fragment of size 806 bp was ligated to the pBAD/JYAMBTAG
frame of 5385 bps. The ligation was performed with a ration of 1:3 (vector:insert) for 1Hr
at room temperature. The product was transformed into DH5α cells and the eluted
product of plasmid extraction was sent for sequencing to confirm ligation and to check
whether the desired product is formed. The plasmid obtained was hence named as pBADCRABPIK106Am. The size of the plasmid is 6415 bps. Similar method was followed to
obtain the pBAD-CRABPIwt* plasmid without the K106Am mutation.
2. 11 Preliminary studies prior to in vivo labeling of CRABP I
2.11.1 Permeability of the unnatural amino acid
The permeability of the 7-hydroxycoumarinyl 4-ethyl glycine was studied by a
fluorescence assay. A single colony of BL21 (DE3) cells harboring the pBADCRABPIK106Am and the pBK-CouRS-D8 plasmids was grown in a 5ml starter culture
with the antibiotics tetracycline and kanamycin at their respective concentrations. The
culture was allowed to grow to its confluence overnight at 370C. This culture was used to
inoculate a 50 ml 2XYT medium to a starting optical density at 600 nm of 0.09. The cells
were allowed to grow at 37 0C at 220 rpm till the optical density at 600 nm reaches 0.68,
which took four and a half hours. At this time the culture was induced with 0.2 %
arabinose and the 7-hydroxycoumarinyl 4-ethyl glycine at a concentration of 1 mM was
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also added (Wang et al., 2006). The cultures were induced for 4 Hrs and then harvested.
Cultures at intervals of 2 Hrs were taken to monitor the fluorescence. The culture samples
were washed in phosphate buffer thrice to remove the external fluorescent molecules and
then centrifuged at 3500 rpm for 10 minutes at 4 0C and washed thrice with autoclaved
deionized water to open up the cells and check the fluorescence of the cytoplasm. The
pellet was resuspended in deionized water and the fluorescence was measured in a
spectrofluorometer. The samples were excited at 366 nm and the emission from 350 nm
to 500 nm was collected.
2.11.2 Toxicity of the unnatural amino acid
Effect of 1 mM 7-hydroxycoumarinyl 4-ethyl glycine synthesized in lab on the growth
pattern of E. coli cells was assessed. This assay provided us with information regarding
the differences in growth patterns when compared to growth in the absence of the amino
acid. The cell viability was measured by optical density measurement at 600 nm and also
by plating the culture at 1 Hr time intervals. The growth curves in comparison with the
wild type were plotted.
2.11.3 Optimization of expression conditions
Labeling of CRABP I was conducted using a final 100 ml volume culture. The plasmids
pBAD-CRABPIK106Am and pBK-CouRS-D8 were co-transformed into BL21 (DE3)
cells. A single colony was picked for preparation of the overnight starter culture in 5 ml
of 2XYT medium with the tetracycline and kanamycin antibiotics. This was used to
inoculate 100 ml of the 2XYT medium supplemented with the antibiotics and 1 mM of
the fluorescent amino acid. The cells were allowed to grow till an O.D 600 nm of 0.5 at
which point they were induced with 0.2 % arabinose according to the protocol (Wang et
al., 2006). The cells were harvested after 12 Hrs. BPER II reagent was used to lyse the
cells and separate the soluble and insoluble fractions. The fluorescent and coomassie
stained gels were observed.
The wild type CRABP I gene cloned into the pBAD vector was used for this purpose.
The pBADCRABPIwt* was transformed into BL21 (DE3) cells and used for these
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assays. The two major parameters are -Time of induction and Concentration of inducerarabinose.
To test the cells were grown as above and at mid-log phase the cells were induced with
0.002 %, 0.02 % and 0.2 % arabinose. Samples were taken at hourly intervals for 6 Hrs
and the soluble fraction was analysed for the presence of the protein. It is observed that
the expression of the CRABP I wt* protein was highest at 0.2 % arabinose induction.
2.12 Expression of labeled protein
To test if suppression of the amber codon protein takes place without the addition of the
unnatural amino in the medium and to also assay and optimize the level of expression of
the labeled protein the nonsense suppression system for Methyl-O-tyrosine was procured
from the Schultz lab. The procedure followed for the expression of the protein was as
follows. 10 and 50 ml cultures were used for expression of CRABPIK106Am. The
pET16bCRABPIK106Am plasmid and the pSupJYRS plasmids were co-transformed into
BL21 (DE3) cells and single colonies of cells were inoculated into 2XYT medium with
ampicillin and chloramphenicol for the preparation of the overnight starter culture. This
was used to inoculate the growth culture to start with an OD at 600 nm of 0.2. It took 3
hrs for the culture to attain an OD of 0.7 at which point the culture was induced with 400
uM IPTG and 1 mM methyl-O-tyrosine was added. The cells were allowed to grow at 37
0

C, 220 rpm for 0.5 Hr. After which the culture was split to two 5 or 25 ml cultures. Both

were grown at 30 0C. One was harvested after 4 Hrs and the other after overnight
induction.
Plasmid stability test was performed on LB, LB+ampicillin+chloramphenicol+IPTG,
LB+ampicillin+chloramphenicol, LB+IPTG agar plates in case of overnight induction to
confirm the presence of both the plasmids during the expression of the protein. It was
confirmed that the plasmids were stable during the whole period.
The harvested cultures were lysed with BPER II reagent and the lysates were analyzed by
coomassie staining, western blotting using anti-CRABP I antibodies and anti-His tag
antibodies.
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CHAPTER 3
MOLECULAR BIOLOGY
3.1 Results
3.1. A Cloning
3.1. A. 1 Removal of the NdeI restriction site from pET16bCRABPIwt* plasmid
The NdeI recognition site present after the start of the CRABP I wt* gene in
pET16bCRABPIwt* plasmid was removed by site directed mutagenesis as mentioned in
chapter 2. The resultant product is shown in Fig 3.1.a. The resultant plasmid was sent for
sequencing and the result analyzed for the absence of the NdeI site at the previous
location. It was observed that the NdeI site was successfully deleted from the earlier site.
3.1. A. 2 Introduction of the NdeI restriction site in pET16bCRABPIwt* plasmid
The NdeI recognition site was introduced after the CRABP I wt* gene by site directed
mutagenesis as mention in the previous chapter. The product obtained was run on an
agarose gel as shown in Fig 3.1.b and subsequently sent for sequencing, the result of
which was analyzed and proven to have the NdeI site after the gene at the desired
location.
3.1. A. 3 Site directed mutagenesis of K106 to amber codon
The Lysine 106 position in CRABP I wt* (pET16bCRABPIwt* plasmid) was
successfully mutated from AAA to UAG by Site directed mutagenesis by PCR as
mentioned in chapter 2. The plasmid obtained as a result was subjected to sequencing and
checked for the mutation at the right position. The mutagenesis hence worked and the
plasmid, pETCRABPIK106Am, obtained was further subjected to the following steps.
3.1. A. 4 Cloning of the CRABPIK106Am gene into pBAD/JYAMB-4TAG-Myo
plasmid
The pETCRABPIK106Am plasmid was PCR amplified with the T7 forward and reverse
primers and the product obtained was 944 bps in length (Fig 3.1.c).
The

pBAD/JYAMB-4TAG-Myo

and

the

PCR

amplification

product

of

the

CRABPIK106Am gene were digested with the NcoI and the NdeI restriction enzymes to
obtain similar sticky ends. The restriction digestion products of the former are observed
in Fig 3.1.d.
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3.1. A. 5 Ligation of the restriction digestion fragments
The CRABPIK106Am fragment of size 806 bps was ligated to the pBAD frame of 5385
bps as per the procedure mentioned in chapter 2.
The plasmid thus obtained was analyzed by sequencing and was named pBADCRABPIK106Am. The size of the plasmid is 6415 bps.

5385bp

508bp

a)

b)

d)

c)

Fig 3.1 Agarose gels representing each stage of the plasmid preparation process. a)Removal
of the NdeI restriction site from pET16bCRABPIwt* plasmid b) Introduction of the NdeI
restriction site from pET16bCRABPIwt* plasmid c) 944 bps long PCR product of
CRABPIK106Am gene d) Restiction digestion fragments of pBAD/JYAMB-4TAG-Myo,
53835 bps and 508 bps respectively.
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CHAPTER 4
SYNTHESIS OF THE FLUORESCENT AMINO ACID
4.1 Results
4.1. A Chemical synthesis of L-(7-hydroxycoumarin-4-yl) ethylglycine
The synthesis procedure was followed as mentioned in chapter 2. The intermediate
product was subsequently obtained and tested by LC-MS (ESI) and 1H-NMR (400
MHz,CDCl3). Expected mass: 465.0 Da (M+Na+), Observed: 464.1 Da (M+Na+). The
obtained NMR spectrum was as expected (Wang et al., 2006, Brun et al., 2004).The
figures of the LC-MS and 1H-NMR are provided in Fig. 4.1 and 4.2.

Fig 4.1 LC-MS (ESI) spectrum of the intermediate product ((2S)-2-benzyloxy carbonyl
amino-5-oxo-heptanedioic acid 1-benzyl ester 7-ethyl ester) in the synthesis of the final
fluorescent amino acid. Expected mass:465.0 Da, found:464.1 Da

The NMR spectrum of the intermediate compound was also procured. The expected
peaks were compared with the obtained peaks (Fig 4.2). The intermediate compound was
hence obtained.
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Fig 4.2 1D H+NMR spectrum of the intermediate compound (2S)-2-benzyloxycarbonyl
amino-5-oxo-heptanedioic acid 1-benzyl ester 7-ethyl ester

The intermediate product was further subjected to the next step to obtain the fluorescent
amino acid. The product was purified using a preparative C-18 column with a 5-45 %
CH3CN gradient as represented in Fig 4.3. The fractions were collected and that from the
11th to 14th minute was rotavaporized and sent for LC-MS.
2.5
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Fig 4.3 HPLC purification of the fluorescent amino acid. The spectrum is shown in this
figure where the fractions pointed were collected.
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ESI-MS crude product has an expected mass of 264.08 Da. The observed mass was 264.0
Da as represented in the ms spectrum in Fig 4.4.

Fig 4.4 LC-MS (ESI) spectrum of the crude fluorescent amino acid prior to HPLC
purification. Expected mass:264.08Da, found:264Da

The HPLC purified fractions were then also tested by LC-MS (ESI) to obtain a purified
compound of required molecular mass as shown in Fig 4.5.
[M-H]-

Fig 4.5 LC-MS (ESI) spectrum of the final fluorescent amino acid product. Expected mass:
264.08 Da, found:261.8 Da
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An absorbance spectrum of the product was performed in 100 mM sodium phosphate
buffer at pH 7.4. The spectrum obtained is shown in Fig 4.6.

Fig 4.6 Absorbance spectrum of the purified fluorescent amino acid in phosphate buffer
pH7.4. Excitation maximum at 340 nm and emission maximum at 450 nm.

The fluorescent amino acid was hence synthesized. The yield of the amino acid was 500
mg from 2 gm of starting compound.
4.1. B Tests to confirm the presence of free amino acid in the product
Ninhydrin test was performed on a TLC plate. The purity of the sample could also be
tested with this. Butanol:Acetic acid:Ethylacetate:water (1:1:1:1) solvent mixture was
determined best for separation of the compound. The amino acid sample was dissolved in
it and loaded on the TLC plate which was then placed in a saturated chromatography
chamber with the solvent. The ninhydrin reagent was prepared in n-Butanol and sprayed
on the air dried TLC plate. The TLC plate was visualized using a hand UV torch. A
picture of the plate was also taken (Fig 4.7 a). A clear band is observed in the case of the
fluorescent amino acid and the band turned positive for ninhydrin.
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4.1. C To test the overall charge of the amino acid:
Pure 7-hydroxycoumarin or umbelliferone is weakly acidic, soluble in hot water and
acetic acid and has a molecular weight of 162.14 Da. The nature of the synthesized amino
acid was tested using agarose gel. The fluorescent amino acid was loaded with glycerol
onto an agarose gel (1 %) with wells made at the center of the gel. Current was applied
and the trace of the fluorescent molecule was followed using the hand UV torch. The
amino acid was found to be moving towards the positive electrode suggesting the anionic
nature of the amino acid (Fig 4.7 b).

UAA

a)

Arg

Pro

-

b)

+

Fig 4.7 Tests to check the free amino acid and overall charge of the amino acid a) ninhydrin
assay to test the presence of the free amino acid. UAA-Unnatural amino acid;Arg-Arginine;
Pro-proline, the product hence is positive for ninhydrin; b) the electrophoretic mobility of
the free amino acid in an agarose gel. The free fluorescent amino acid is observed to be
negative in charge.

This was further confirmed by fluorometric assays of the compound in different solvents
and pH conditions. Scientists (Colambano and Troccoli, 1985) postulate that 7hydroxycoumarin exists in equilibrium among cationic, anionic and neutral species. Each
of these species can be differentiated by the emission and excitation maxima which are
specific. The neutral species emits maximum at 400 nm when excited at 325 nm. The

38

cationic form emits at 431 nm when excited at 345 nm. The anionic form emits at 453 nm
when excited at 366 nm.
The compound was dissolved in water and the emission spectra were collected for three
different excitation maxima (Fig 4.8 a).
It has been found from the emission spectra that the compound is predominantly in the
anionic form. pH can also have an effect on the fluorescence emission of the compound is
shown. The intensity of fluorescence decreases with increasing pH (Fig 4.8 b)
(Colombano and Troccoli, 1985), thus making it a good candidate for being a pH sensor
(Budisa et al., 2002).

Fig 4.8 Emission scans at various excitation wavelengths and pH. a)Emission scans of the
fluorescent amino acid at different excitation wavelengths of 325, 345 and 366 nm. b)
Emission spectra of the fluorescent amino acid at different pH conditions while excited at
366 nm.

This is because of intramolecular charge migration and can be used as a tool in protein
folding, protein membrane interaction, protein-protein interaction, protein-ligand
interactions studies and other applications (Mills et al., 2009; Gök et al., 2008;
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Uttamapinant et al., 2010). Hence, the labeled proteins can act as protein based molecular
sensors.
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CHAPTER 5
PRELIMINARY STUDIES PRIOR TO LABELING
5.1 Results
5.1. A Permeability of the unnatural amino acid into the E. coli cells
The emission maximum for the 2XYT medium alone is 400 nm. With the 7hydroxycoumarinyl 4-ethyl glycine the emission maximum shifts to 450 nm. The pellet
has no fluorescence before addition of the 7-hydroxycoumarinyl 4-ethyl glycine and even
after 2 Hrs of 7-hydroxycoumarinyl 4-ethyl glycine addition. In the culture with the 7hydroxycoumarinyl 4-ethyl glycine added at the time of induction, the pellet appears to
be non-fluorescent even 2 Hrs later. The fluorescence is observed after 4 Hrs depicting
that increased induction time is effective for permeability of the 7-hydroxycoumarinyl 4ethyl glycine into the cells (Fig 5.1). Hence, it can be concluded that the permeability of
the fluorescent amino acid increases with time and an induction period greater than 4 Hrs
is best suitable for labeling to be efficient if addition of the fluorescent amino acid is done
at the time of induction. There is evidence that the growth of the bacteria is also affected
after the addition of the fluorescent amino acid at the time of induction as compared to at
the start of the culture.
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Yellow- 4Hrs post induction and
addition of 7-hydroxycoumarinyl 4ethyl glycine
Purple-Culture at induction time
(with 7-hydroxycoumarinyl 4-ethyl
glycine added at the start)
Blue-4Hrs post induction of the
culture (with 7-hydroxycoumarinyl
4-ethyl glycine added at the start)
Green-2XYT+7-hydroxycoumarinyl
4-ethyl glycine
Cyan-2XYT
Red-Culture with no 7hydroxycoumarinyl 4-ethyl glycine
Pink-Culture at start (with 7hydroxycoumarinyl 4-ethyl glycine
added at the start)
Light blue- Ethanol

Fig 5.1 Permeability of the fluorescent amino acid, 7-hydroxycoumarinyl 4-ethyl glycine
into BL21 (DE3) cells. The emission spectra are depicted by different colors which are
mentioned in the legend on the right.

5.1.B Toxicity of 7-hydroxycoumarinyl 4-ethyl glycine
Effect of 1mM 7-hydroxycoumarinyl 4-ethyl glycine synthesized in lab on the growth
pattern of E. coli cells was assessed. This assay provided us with information regarding
the differences in growth patterns when compared to growth in the absence of the amino
acid. The cell viability was measured by optical density measurement at 600 nm and also
by plating the culture at 1 Hr time intervals. The growth curves when compared to the
wild type were plotted (Fig 5.2).
Effect of HCEG on growth of BL21(DE3)
2.5

O .D at 600n m

2
1.5
1
0.5

Blue-No HCEG
Pink-1mMHCEG at induction

T im e
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
5.5
6
6.5
7
7.5
8
8.5
9
9.5
10

0

Time in Hrs

Fig 5.2 Effect of the fluorescent amino acid on the growth of BL21(DE3) cells. The O.D at
600 nm was measured at 30 minutes interval. 1mM of the fluorescent amino acid was added
at induction time of 3 Hrs
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It is observed that there is a difference in the growth pattern after induction. The number
of colonies that grew on LB agar after the induction period and addition of the
fluorescent amino acid when compared to the culture without the addition of the
fluorescent amino acid also had a similar effect. These studies show that the fluorescent
amino acid has an influence on the growth of the bacteria. There is a slight retardation of
the growth after the addition of the fluorescent amino acid. This has to be taken into
consideration in terms of regulation of the concentration of the amino acid provided to
the culture.
5.1. C Preliminary expression of labeled protein
Preliminary expression studies were carried out using the method mentioned in chapter 2
and the supernatant samples were loaded and run on a SDS PAGE gel which was
coommassie stained. Prior to staining, the gel was observed under UV light and faint
bands were observed, however an image was not recorded. The coommassie stained gel
is shown in Fig 5.3. From the gel it is clear that a corresponding band is observed for the
CRABPK106Am protein when expressed with the fluorescent amino acid as pointed with
the arrow. However, there was no band in the previous lane, which was a repeat of the
same expression test (duplicate). The last lane to the right shows the wild type CRABP I
expressed under standard conditions. Hence, the result seemed very inconsistent.
kDa
116

U

pBADmyo
K106A Wt*
U
I
I
I
I
I
-HCEG +HCEG
+HCEG

66.2
45
35
25
18.4
14.4

Fig 5.3 Expression test of CRABP I labeled with the fluorescent amino acid at the K106
position; Coomassie stained SDS-PAGE gel;I=Induced, U=uninduced. Evidence of
labeled protein has to further be observed clearly due to lack of consistency and
optimization of expression.
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5.1.D Optimization of the conditions for protein expression
Since the expression level of the protein seemed to very low the parameters for
expression of protein were altered and assayed. The wild type CRABP I gene cloned into
the pBAD vector was used for this purpose. The pBADCRABPIwt* was transformed into
BL21 (DE3) cells and used for these assays. The two major parameters are -Time of
induction and Concentration of inducer-arabinose.
To test these cells were grown as above and at mid-log phase the cells were induced with
0.002 %, 0.02 % and 0.2 % arabinose. Samples were taken at hourly intervals for 6Hrs
and the soluble fraction was analysed for the presence of the protein. It is observed that
the expression of the CRABP I wt* protein was highest at 0.2 % arabinose induction.
However, the protein expression level was not high as seen in the Fig 5.4. The increase in
the level of the protein can be observed with time i.e 4 Hrs.
kDa
116

1Hr

2Hr

3Hr

4Hr

5Hr

6Hr

66.2
45
35
25
18.4
14.4

Fig 5.4 Optimization of the arabinose concentration for induction. This is a Coomassie
stained SDS-PAGE gel of CRABP I wt* expressed in the pBAD system, with hourly samples
after induction with 0.2 % arabinose. An increased expression is observed over time as
marked within the rectangle.

5.1. E Use of an alternative suppression system
On performing a small scale labeling experiment using the same system mentioned above
it was observed that no labeled protein was obtained. The system hence did not have
consistency over different culture volumes. The question of optimizing the conditions for
suppression to occur arose. To test and study if suppression was taking place a different
system was to be used keeping in mind the low amount of the fluorescent amino acid
present. The Methyl-O-tyrosine system seemed to be suitable for studying the
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suppression. The plasmid required for this system to work was obtained from the Schultz
group. The methyl-O-tyrosine is easier for studies when compared to the fluorescent
amino acid as it is commercially available.
5.1.F Toxicity and effect of Methyl-O-Tyrosine on growth of bacteria
Similar growth effect assay, as done for the fluorescent amino acid was conducted for the
Methyl-O-tyrosine. 2 mM of methyl-O-Tyrosine was added at the time of induction in
one set of culture. The growth curves suggest that the growth of the bacteria is effected
by the concentration of the amino acid in the medium. The amino acid was added in both
the cases at the time of induction i.e. at 3.5 Hrs. It is observed that the growth of the
bacteria in 1 mM concentration of the amino acid is similar to the control and hence has
no detrimental effect on the cells (Fig 5.5).
Effect of methyl-O-Tyrosine on growth of BL21(DE3)
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Fig 5.5 Effect of growth of BL21(DE3) cells by methyl-O-tyrosine by growth curve
experiment. Higher concentrations of the amino acid is harmful to the cells, but a
concentration of 1 mM is optimum for growth.
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CHAPTER 6
EXPRESSION OF THE LABELED PROTEIN
6.1 Results
6.1. A Suppression assay-Expression of protein labeled with Methyl-O-tyrosine
To test if suppression of the amber codon protein takes place without the addition of the
unnatural amino in the medium and to also assay and optimize the level of expression of
the labeled protein the nonsense suppression system for Methyl-O-tyrosine was procured
from the Schultz lab. The procedure followed for the expression of the protein was as
follows. 10 and 50 ml cultures were used for expression of CRABPIK106Am. The
pET16bCRABPIK106Am plasmid and the pSupJYRS plasmids were co-transformed into
BL21 (DE3) cells and single colonies of cells were inoculated into 2XYT medium with
ampicillin and chloramphenicol for the preparation of the overnight starter culture. This
was used to inoculate the growth culture to start with an OD at 600 nm of 0.2. It took 3
Hrs for the culture to attain an OD of 0.7 at which point the culture was induced with 400
uM IPTG and 1 mM methyl-O-tyrosine was added. The cells were allowed to grow at 37
0

C, 220 rpm for 0.5 Hr. After which the culture was split to two 5 or 25 ml cultures. Both

were grown at 30 0C. One was harvested after 4 Hrs and the other after overnight
induction.
Plasmid stability test was performed on LB, LB+ampicillin+chloramphenicol+IPTG,
LB+ampicillin+chloramphenicol, LB+IPTG agar plates in case of overnight induction to
confirm the presence of both the plasmids during the expression of the protein. It was
confirmed that the plasmids were stable during the whole period.
The harvested cultures were lysed with BPER II reagent and the lysates were analyzed by
coommassie staining, western blotting using anti-CRABP I antibodies and anti-His tag
antibodies.
The harvested cultures were lysed with BPER II reagent and the lysates were analyzed by
coommassie staining, western blotting using anti-CRABP I antibodies and anti-His tag
antibodies.
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CRABPIwt*
-MT
+MT
U I4 Ion U I4 Ion
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CRABPIK106Am CRABPIK106Am CRABPIwt*
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-MT
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CRABPIK106Am
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U I4 Ion U I4 Ion
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14.4
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d
Fig 6.1 Expression of Methyl-O-tyrosine labeled CRABPI. a) Coomassie stained SDS-PAGE gel of
the suppression test. b) Western blot using anti-CRABP I antibodies. c) Small scale Ni-NTA
purification of the induced overnight fraction of the pET16bCRABPIK106Am+pSUPJYRS +MT
culture. d) Western blot as b) with anti-Histag antibodies. MT=Methyl-O-tyrosine, U=Uninduced,I
4=Induced for 4Hrs,Ion=Induced overnight.

In Fig 6.1 a, it is observed that the full length protein is expressed in case of expression
from pET16bCRABPIwt*+pSupJYRS both in the absence and in the presence of MethylO-tyrosine. This shows that the presence of the amino acid and the specific amino acyl
synthetase enzyme does not effect the expression of the wild type protein. The presence
of the protein in the uninduced cultures is due to the leakiness of expression. The
expression of the protein from the pET16bCRABPIK106Am+pSupJYRS culture on the
other hand shows different results. Truncated protein bands can be observed in this case.
It was expected that in the presence of the amino acid, full length protein should be
expressed with the label and in the absence of the amino acid, only truncated products
should be observed. This result is not clear from Fig 6.1 a, but is clear from Fig 6.1 b and
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Fig 6.1 d western blots wherein clear bands are observed in case of the samples with the
unnatural amino acid while only truncated proteins are observed in samples without the
amino acid. In case of the 4 Hr induction sample highlighted in d) two distinct bands are
observed, which can be judged as being the full length and the truncated version of the
protein. These bands are merged in case of the overnight induction sample and hence
appear as one single band. The reason for the presence of multiple bands is not clear and
could be a result of degradation and/or oligomerization. It is clear in the western blot
results that truncated products are formed to a large extent. This is due to the type of
overexpression system used and the mismatch between the protein synthesis machinery
and the ribosomal pause at the amber stop codon. A small scale purification of the
overnight induced mutant culture with methyl tyrosine (60 µl) was subjected to Ni-NTA
purification due to the presence of the N-terminal His tag. The result of which is shown
in Fig 6.1 c. The identity of the bands in terms of protein length and presence of
incorporated amino acid has to be learnt by mass spectrometry.
6.1. B Expression of the 7-hydroxycoumarinyl-4-ethylglycine labeled CRABPI
Earlier attempts to suppress the K106amber mutation in CRABP I with the fluorescent
amino acid was made in a 50 ml culture. The protocol used was similar to the one used
for Methyl-O-tyrosine. The cultures were induced overnight and the samples were
harvested and lysed in BPER II following which the soluble and insoluble fractions were
separated and analyzed. Uninduced cultures were also grown as controls. The
fluorescence of the fractions was tested and the identity of the proteins was tested by
western blot. Multiple bands were observed (Fig 6.2 b) the smallest being around 15 kDa
(Fig 6.2 a) which resembles the truncated version of the protein. A small fraction of the
soluble fraction was purified using a Ni-NTA beads and the gel loaded with the samples
was exposed to a UV torch (Fig 6.2 c) and a western blot with anti-CRABP I (Fig 6.2 d)
antibodies was performed and it was found that a series of truncated products were
present. Similar result was observed with Methyl-O-tyrosine labeling and rechecking the
sequence of the plasmids lead to the conclusion that these results were due to primer
duplication in the sequence due to which two stop codons were inserted. However, the
presence of the fluorescent band is good evidence that the method works.
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Fig 6.2 Expression of 7-hydroxycoumarinyl-4-ethylglycine labeled CRABP I at K106
position. a) Coomassie stained SDS-PAGE gel. b) UV exposed SDS-PAGE gel prior to
coomassie staining. Uninduced cultures and cultures without the addition of the fluorescent
amino acid showed no fluorescence. Truncated products observed. The arrow marks show
the protein of interest and the truncated and higher molecular weight versions of the same
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CHAPTER 7
CONCLUSIONS AND FUTURE DIRECTIONS
Results of these experiments are promising and give hope for the labeling to occur and
further experiments to express the fluorescent amino acid labeled protein with the
corrected plasmid sequence will be done consequently. To facilitate the separation of full
length labeled protein from truncated products, C-terminal His tagged protein should be
used. Choosing an earlier position in the protein sequence would further avoid the
synthesis of truncated protein and ease the labeling process. General rules for selection of
a site for amber mutation allowing for better suppression of the protein have been learned
in this process which will help in choosing sites for incorporation. The pEVOL plasmid
system for HCEG incorporation has been requested from the Schultz group. This system
will offer a better expression level of the HCEG labeled CRABPI.
In general the performed experiments have paved the way for further studies on in vivo
incorporation of unnatural amino acids in E. coli. Successful incorporation of the
fluorescent amino acid into the protein will provide a tool enabling protein dynamics
studies by in vivo FRET based investigations. These experiments have educated us
critical aspects of the nonsense suppression technique which will eventually help in
setting up future experiments and exploiting this technique as a tool for exploring the
unknown in not only CRABP I folding but also allow for studies in other systems.
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